Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance

CRISPR-Cas9 gene editing of human hematopoietic stem and progenitor (HSPC) cells holds great promise for disease treatment by cellular therapy and other methodologies. However, the variables that can affect treatment of relevant diseases in the real world are still being elucidated. A critical part of this involves implementing an optimized gene editing and cell culture methodology. In this webinar, Dr. Marta Walasek and Ms. Danielle Nguyen Truong describe tips and tricks for effective genome editing of CD34⁺ cells, methods to evaluate genome editing efficiency, as well as optimal pre- and post- editing culture conditions to maintain HSPC function and long-term editing effects.
Publish Date: May 30, 2022

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.